|Articles|February 1, 2002

New Approaches to the Treatment of Migraine: Clinical and Economic Impact
Volume 8
Issue 3 Suppl

Almotriptan: A Review of Pharmacology, Clinical Efficacy, and Tolerability

Author(s)Randal L. Von Seggern, PharmD, BCPS

Download PDF: Almotriptan: A Review of Pharmacology, Clinical Efficacy, and Tolerability

Articles in this issue

about 24 years ago

Article

Participating Faculty

about 24 years ago

Article

Introduction

about 24 years ago

Article

Migraine: Diagnosis, Management, and New Treatment Options

about 24 years ago

Article

Economic Comparison of Oral Triptans for Management of Acute Migraine: Implications for Managed Care

about 24 years ago

Article

Health Outcomes Evaluations: Estimating the Impact of Almotriptan in Managed Care Settings

about 24 years ago

Article

Almotriptan Versus Sumatriptan in Migraine Treatment: Direct Medical Costs of Managing Adverse Chest Symptoms

about 24 years ago

Article

Cost Savings in Migraine Associated with Less Chest Pain on New Triptan Therapy

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Almotriptan: A Review of Pharmacology, Clinical Efficacy, and Tolerability

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

Virtual Reality Intervention Increased Empathy for Patients With MG

Strong Patient–Doctor Communication Improves Glaucoma Care: Ariana Levin, MD

Most Patients With MCL in Study of Pirtobrutinib Show Stable or Improved Physical Symptoms, QOL

Mental Health Distress in Nonmelanoma Skin Cancer Largely Driven by Sociodemographic, Comorbid Factors

AI-Supported Mammography Caught More Cancers During Screening